RxSight (RXST) Net Margin (2020 - 2026)
RxSight's (RXST) quarterly Net Margin came in at 35.85% in Q2 2026, down 81.0% on a YoY basis from 188.7% in Q2 2025, and up 30.27% quarter-over-quarter from 51.42% in Q1 2026.
Powered by 
Analysis
RxSight (RXST) Net Margin (2020 - 2026) Analysis & Trends
RxSight (RXST) has reported Net Margin for 7 consecutive years, with 35.85% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin fell 81.0% year-over-year to 35.85%; the trailing twelve-month figure through Jun 2026 stood at 30.35% (down 1236.0% YoY), and the FY2025 full-year result was 22.84%, down 509.0% from the prior year.
- Net Margin advanced to 35.85% in Q2 2026 per RXST's latest filing, from 51.42% in the prior quarter.
- Across five years, Net Margin topped out at 3.65% in Q4 2023 and bottomed at 196.78% in Q1 2022.
- Historically, Net Margin has averaged 51.5% across 5 years, with a median of 33.7% in 2025.
- The sharpest annual moves came in 2022 and 2026: Net Margin soared 17687 bps in 2022, then sank 2980 bps in 2026.
- Over 5 years, Net Margin stood at 9.86% in 2022, then soared by 137 bps to 3.65% in 2023, then slumped by 109 bps to 0.33% in 2024, then slumped by 749 bps to 2.83% in 2025, then slumped by 1168 bps to 35.85% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 35.85%, 51.42%, and 2.83% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 7.37% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 28.46% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 15.17% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 19.37% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 16.67% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 13.87% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 19.04% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 13.47% |
| 10 | RxSight | 265.13 Mn | -139.12 Mn | - | -35.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.85% |
| Mar 31, 2026 | -51.42% |
| Dec 31, 2025 | -2.83% |
| Sep 30, 2025 | -32.35% |
| Jun 30, 2025 | -35.04% |
| Mar 31, 2025 | -21.61% |
| Dec 31, 2024 | -0.33% |
| Sep 30, 2024 | -17.95% |
| Jun 30, 2024 | -17.42% |
| Mar 31, 2024 | -30.83% |
| Dec 31, 2023 | 3.65% |
| Sep 30, 2023 | -55.93% |
| Jun 30, 2023 | -66.33% |
| Mar 31, 2023 | -75.54% |
| Dec 31, 2022 | -9.86% |
| Sep 30, 2022 | -133.32% |
| Jun 30, 2022 | -147.29% |
| Mar 31, 2022 | -196.78% |
| Dec 31, 2021 | -186.73% |
| Sep 30, 2021 | -219.03% |